Photo credit: Hashem Al-Ghaili
Within the next 20-30 years we may have space elevators, and then this EctoLife artificial womb facility. The first step is for prospective parents to have their eggs and sperm combined through in vitro fertilization, enabling them to select only viable and genetically superior embryos, or those free from genetic issues as well as birth defects.
EctoLife would also allow for parents to genetically engineer their embryo before implanting it into the artificial womb utilizing the CRISPR-Cas 9 gene editing tool. This would enable one to fix any inherited genetic diseases that are part of your family history so that the baby and their offspring will live a perfectly healthy life free of any genetic diseases. Each facility would make extensive use of AI to provide each engineered baby with custom nutrients tailored to their needs and monitor their physical features to detect any potential abnormalities from normal gestation.
The assistive reproduction technology, or ART, market is already large, and it is only getting larger. According to the American Society of Reproductive Medicine, the current cost of a single IVF cycle is $12,400, with the average couple spending $19,234. The largest market for IVF treatment is currently Europe, followed by the U.S. However, the fastest-growing market is the Asia-Pacific region,” according to Science and Stuff.
Source link
